| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
89bio Inc (NASDAQ: ETNB)
ETNB Technical Analysis
5
| As on 29th Oct 2025 ETNB STOCK Price closed @ 14.84 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.32 & Strong Buy for SHORT-TERM with Stoploss of 8.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ETNBSTOCK Price
| Open | 14.83 | Change | Price | % |
| High | 14.87 | 1 Day | 0.00 | 0.00 |
| Low | 14.82 | 1 Week | 0.04 | 0.27 |
| Close | 14.84 | 1 Month | 6.76 | 83.66 |
| Volume | 55592633 | 1 Year | 6.14 | 70.57 |
| 52 Week High 14.96 | 52 Week Low 4.83 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| HBIO | 0.63 | 40.00% |
| CMBM | 3.75 | 27.12% |
| NVDA | 202.89 | -2.00% |
| BYND | 1.65 | -10.33% |
| ONDS | 6.29 | -6.81% |
| LMDX | 0.02 | 0.00% |
| OPEN | 7.34 | -4.05% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ETNB Daily Charts |
ETNB Intraday Charts |
Whats New @ Bazaartrend |
ETNB Free Analysis |
|
|
ETNB Important Levels Intraday
| RESISTANCE | 14.94 |
| RESISTANCE | 14.91 |
| RESISTANCE | 14.89 |
| RESISTANCE | 14.87 |
| SUPPORT | 14.81 |
| SUPPORT | 14.79 |
| SUPPORT | 14.77 |
| SUPPORT | 14.74 |
ETNB Forecast October 2025
| 4th UP Forecast | 20.6 |
| 3rd UP Forecast | 18.75 |
| 2nd UP Forecast | 17.61 |
| 1st UP Forecast | 16.47 |
| 1st DOWN Forecast | 13.21 |
| 2nd DOWN Forecast | 12.07 |
| 3rd DOWN Forecast | 10.93 |
| 4th DOWN Forecast | 9.08 |
ETNB Weekly Forecast
| 4th UP Forecast | 17.29 |
| 3rd UP Forecast | 16.50 |
| 2nd UP Forecast | 16.02 |
| 1st UP Forecast | 15.53 |
| 1st DOWN Forecast | 14.15 |
| 2nd DOWN Forecast | 13.66 |
| 3rd DOWN Forecast | 13.18 |
| 4th DOWN Forecast | 12.39 |
ETNB Forecast2025
| 4th UP Forecast | 35.84 |
| 3rd UP Forecast | 29.11 |
| 2nd UP Forecast | 24.94 |
| 1st UP Forecast | 20.78 |
| 1st DOWN Forecast | 8.9 |
| 2nd DOWN Forecast | 4.74 |
| 3rd DOWN Forecast | 0.57 |
| 4th DOWN Forecast | -6.16 |
89bio Inc ( NASDAQ USA Symbol : ETNB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ETNB Business Profile
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California. Address: 142 Sansome Street, San Francisco, CA, United States, 94104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service